The views, information, or opinions expressed in the Industry News RSS feed belong solely to the author and do not necessarily represent those of IDEX Health & Science and its employees.

    II-VI Reports Forecast-Beating Fourth-Quarter Results at Close of Fiscal Year

    Article obtained from Photonics RSS Feed.

    II-VI has announced its fourth-quarter and fiscal year results. The company reported record quarterly revenues of $746.2 million (up $119.2 million from the quarter ending in March) and quarterly earnings per share (EPS) of $1.18 (up $0.53 year over year). II-VI also reported a record full-year cash flow from operations of more than $297.3 million, and a full-year revenue of $2.38 billion — an increase of $1.36 billion from 2019.

    “In the fourth quarter, we remained and continue to remain vigilant and steadfast in ensuring the health and safety of our global workforce while striving to meet our customers’ growing expectations despite the continuation and acceleration of COVID-19,” II-VI CEO Vincent D….

    Aug, 13 2020 |

    IDEX Health & Science is the global authority in fluidics and optics, bringing to life advanced optofluidic technologies with our products, people, and engineering expertise. Intelligent solutions for life.